India, Nov. 17 -- * Rimegepant is an orally disintegrating tablet (ODT) - a class of medications called calcitonin gene-related peptide (CGRP) receptor antagonist * Approved by DCGI for acute treatment of migraine with or without aura in adults with a previous insufficient response to Triptans, it is now available in 75mg oral disintegrating tablet and can be taken with or without meals
Bangalore : Pfizer has announced the launch of a Rimegepant ODT in India for acute treatment of migraine, with or without aura, in adults with a previous insufficient response to triptan. The new medication delivers rapid and sustained pain relief lasting up to 48 hours post-treatment, while not associated with the risk of medication overuse headaches. It a...